The Journal of Organic Chemistry
Note
mp 281−283 °C, lit.7b mp 280−283 °C, lit.8b mp 282−284 °C; H
1
9-(Bromomethyl)-2,3,6,7-tetramethoxyphenanthrene (4).
To a solution of compound 8 (4.9 g, 15 mmol) in DCM (300 mL)
was added PBr3 (6.1 g, 22.5 mmol in DCM (40 mL)) dropwise
through a constant pressure funnel at 0 °C. The reaction mixture was
stirred at this temperature for 2 h and then quenched with ice−water
(200 mL). After separation, the organic layer was washed with ice−
water (200 mL × 5) and brine (200 mL), dried over Na2SO4, and
concentrated in vacuo to give bromide 4 (5.6 g, 14.4 mmol, 96%) as a
white solid: mp 207−209 °C, lit.19 195−197 °C; 1H NMR (400 MHz,
CDCl3) δ 7.75 (s, 1H), 7.68 (s, 1H), 7.60 (s, 1H), 7.47 (s, 1H), 7.12
(s, 1H), 4.93 (s, 2H), 4.10 (s, 3H), 4.09 (s, 3H), 4.08 (s, 3H), 3.99 (s,
3H); 13C NMR (100 MHz, CDCl3) δ 149.9, 149.3, 149.0, 148.7,
128.7, 126.4, 125.6, 125.2, 124.0, 108.4, 104.9, 103.3, 102.7, 56.1, 56.1,
56.0, 55.9, 33.8.
NMR (400 MHz, CDCl3) δ 7.83 (s, 2H), 7.31 (s, 1H), 7.16 (s, 1H),
4.63 (d, J = 14.7 Hz, 1H), 4.12 (s, 6H), 4.06 (s, 6H), 3.68 (d, J = 14.6
Hz, 1H), 3.48 (t, J = 8.1 Hz, 1H), 3.37 (d, J = 16.1 Hz, 1H), 2.97−2.86
(m, 1H), 2.48 (d, J = 8.8 Hz, 2H), 2.25 (d, J = 5.6 Hz, 1H), 2.04 (d, J
= 7.5 Hz, 1H), 1.94 (s, 1H), 1.79 (d, J = 9.7 Hz, 1H). 13C NMR (100
MHz, CDCl3) δ 148.7, 148.5, 148.4, 126.3, 126.1, 125.9, 124.4, 123.6,
123.4, 104.0, 103.4, 103.3, 103.1, 60.2, 56.1, 55.9, 55.8, 55.2, 54.0, 33.8,
31.3, 21.6; [α]D25 +82.8 (c 0.5, CHCl3), lit.7b [α]2D2 +78.9 (c 0.5,
CHCl3); ee >99%, determined by HPLC; HRMS (ESI) calcd for
C24H29NO4 (M + H)+ 394.2018, found 394.2022.
ASSOCIATED CONTENT
■
S
* Supporting Information
(R)-3-((S)-5-Azido-2-((2,3,6,7-tetramethoxyphenanthren-9-
yl)methyl)pentanoyl)-4-isopropyloxazolidin-2-one (9). To a
solution of compound 5 (0.8 g, 3.1 mmol) in THF (50 mL) was
added KHMDS (3.4 mL, 3.4 mmol, 1 M in THF) via a syringe
dropwise at −78 °C under an atmosphere of Ar. One hour later,
bromide 4 (1.2 g, 2.9 mmol in THF (80 mL)) was added slowly via a
syringe. The reaction mixture was stirred at this temperature overnight
and then quenched with aqueous saturated ammonium chloride. After
separation, the aqueous layer was extracted with EtOAc (100 mL × 3).
The combined organic phase was washed with brine (100 mL × 2),
dried over Na2SO4, and concentrated in vacuo. The residue was
purified by column chromatography on silica gel to give compound 9
(1.4 g, 2.4 mmol, 84%) as a white solid: mp 69−71 °C; [α]2D5 −26.5 (c
1
Copies of H and 13C NMR spectra for compounds 3−7, 9,
and (S)-tylophorine, and HPLC for (S)-tylophorine and
racemic tylophorine. This material is available free of charge
AUTHOR INFORMATION
Corresponding Author
■
Author Contributions
†These authors contributed equally to this work.
Notes
1
1.35, CHCl3); H NMR (400 MHz, CDCl3) δ 7.81 (s, 1H), 7.75 (s,
The authors declare no competing financial interest.
1H), 7.56 (s, 1H), 7.43 (s, 1H), 7.14 (s, 1H), 4.63−4.53 (m, 1H),
4.49−4.42 (m, 1H), 4.20 (t, J = 8.8 Hz, 1H), 4.11 (s, 3H), 4.11 (s,
6H), 4.10−4.06 (m, 1H), 4.01 (s, 3H), 3.58 (dd, J = 13.2, 8.0 Hz, 1H),
3.20 (t, J = 6.8 Hz, 2H), 3.12 (dd, J = 13.2, 8.0 Hz, 1H), 2.12−2.01 (m,
1H), 1.94−1.83 (m, 1H), 1.64−1.43 (m, 3H); 13C NMR (100 MHz,
CDCl3) δ 175.8, 153.6, 149.1, 149.0, 148.89, 148.8, 130.1, 126.1,
126.0, 125.4, 124.9, 124.0, 108.0, 105.1, 103.4, 102.8, 62.9, 58.4, 56.2,
56.1, 56.0, 56.0, 51.2, 42. 6, 36.8, 29.0, 28.3, 26.8, 17.9, 13.8; HRMS
(ESI) calcd for C30H36N4NaO7 (M + Na)+ 587.2476, found 587.2479.
(S)-5-Azido-2-((2,3,6,7-tetramethoxyphenanthren-9-yl)-
methyl)pentanal (3). To a solution of compound 9 (0.60 g, 1.06
mmol) in DCM (80 mL) was added DIBAL-H (3.2 mL, 3.2 mmol, 1
M in hexane) at −78 °C under an atmosphere of Ar. The reaction
mixture was stirred at this temperature overnight and then quenched
with aqueous saturated ammonium chloride. After separation, the
aqueous layer was extracted with DCM (50 mL × 2). The combined
organic phase was washed with brine (100 mL × 2), dried over
Na2SO4, and concentrated in vacuo. The residue was purified by
column chromatography on silica gel to give azido aldehyde 3 (0.40 g,
87%) as a white solid: mp 86−88 °C; [α]2D5 −22.2 (c 1.03, CHCl3); 1H
NMR (400 MHz, CDCl3) δ 9.77 (d, J = 2.4 Hz, 1H), 7.86 (s, 1H),
7.78 (s, 1H), 7.42 (s, 1H), 7.32 (s, 1H), 7.18 (s, 1H), 4.14 (s, 3H),
4.13 (s, 3H), 4.06 (s, 3H), 4.04 (s, 3H), 3.51 (dd, J = 14.6, 7.0 Hz,
1H), 3.32−3.20 (m, 2H), 3.09 (dd, J = 14.6, 7.0 Hz, 1H), 2.90−2.82
(m, 1H), 1.94−1.84 (m, 1H), 1.77−1.67 (m, 2H), 1.65−1.55 (m, 1H);
13C NMR (100 MHz, CDCl3) δ 204.1, 149.2, 149.0, 148.8, 129.9,
ACKNOWLEDGMENTS
■
We are grateful to the National Key Project for Basic Research
(2010CB126106), the National Natural Science Foundation of
China (21132003, 21121002), the Tianjin Natural Science
Foundation (11JCZDJC20500), and the National Key
Technology Research and Development Program
(2011BAE06B05, 2012BAK25B03-3) for generous financial
support for our programs. We thank China Agricultural
University for supplying some chemical reagents.
REFERENCES
■
(1) (a) Ratnagiriswaran, A. N.; Venkatachalam, K. Indian J. Med. Res.
1935, 22, 433−441. (b) Mulchandani, N. B.; Venkatachalam, S. R.
Phytochemistry 1976, 15, 1561−1563.
(2) Chemler, S. R. Curr. Bioact. Compd. 2009, 5, 2−19 and references
therein.
(3) (a) Gopalakrishnan, C.; Shankaranarayan, D.; Kameswarn, L.;
Natarajan, S. J. Med. Res. 1979, 69, 513−520. (b) Gopalakrishnan, C.;
Shankaranarayanan, D.; Nazimudeen, S. K.; Kameswaran, L. Indian J.
Med. Res. 1980, 71, 940−948. (c) You, X.; Pan, M.; Gao, W.; Shiah, H.
S.; Tao, J.; Zhang, D.; Koumpouras, F.; Wang, S.; Zhao, H.; Madri, J.
A.; Baker, D.; Cheng, Y. C.; Yin, Z. Arthritis Rheum. 2006, 54, 877−
886. (d) Yang, C. W.; Chen, W. L.; Wu, P. L.; Tseng, H. Y.; Lee, S. J.
Mol. Pharmacol. 2006, 69, 749−758.
(4) Wu, C. M.; Yang, C. W.; Lee, Y. Z.; Chuang, T. H.; Wu, P. L.;
Chao, Y. S.; Lee, S. J. Biochem. Biophys. Res. Commun. 2009, 386, 140−
145.
(5) Lee, S. K.; Nam, K. A.; Heo, Y. H. Planta Med. 2003, 69, 21−25.
(6) (a) Staerk, D.; Christensen, J.; Lemmich, E.; Duus, J. O.; Olsen,
C. E.; Jaroszewski, J. W. J. Nat. Prod. 2000, 63, 1584−1586. (b) Gao,
W.; Lam, W.; Zhong, S.; Kaczmarek, C.; Baker, D. C.; Cheng, Y. C.
Cancer Res. 2004, 64, 678−688.
(7) For the most recent examples, see: (a) Yang, X.; Shi, Q.; Bastow,
K. F.; Lee, K. H. Org. Lett. 2010, 12, 1416−1419. (b) Stoye, A.; Opatz,
T. Org. Lett. 2010, 12, 2140−2141. (c) Cui, M.; Song, H.; Feng, A.;
Wang, Z.; Wang, Q. J. Org. Chem. 2010, 75, 7018−7021. (d) Georg,
G.. I.; Niphakis, M. J. J. Org. Chem. 2010, 75, 6019−6022. (e) Wolfe, J.
P.; Mai, D. N. J. Am. Chem. Soc. 2010, 132, 12157−12159. (f) Georg,
G. I.; Niphakis, M. J. Org. Lett. 2011, 13, 196−199. (g) Hsu, S. F.; Ko,
126.1, 125.2, 125.2, 124.9, 123.9, 108.1, 104.4, 103.7, 102.8, 56.1, 56.1,
55.9, 55.9, 51.3, 51.2, 33.2, 26.5, 26.4; HRMS (ESI) calcd for
C24H26N3O5 (M − H)− 436.1878, found 436.1874.
(S)-Tylophorine. To a solution of azido aldehyde 3 (150 mg, 0.34
mmol) in DCM (30 mL) was added CF3COOH (1.5 mL) in a
dropwise manner at room temperature. Thirty minutes later, azido
aldehyde 3 vanished (monitored by TLC), and then (CF3CO)2O (1.5
mL) was added to the reaction mixture dropwise. Twenty minutes
later, aqueous KOH was added until the pH of the reaction mixture
was about 5, and then sodium borohydride (42 mg, 1.1 mmol) was
added in one portion. Thirty minutes later, the reaction was quenched
with water (20 mL). After separation, the aqueous layer was extracted
with DCM (20 mL × 2), and the combined organic phase was washed
with brine (20 mL × 2), dried over Na2SO4, and concentrated in
vacuo. The residue was purified by column chromatography on basic
Al2O3 to give (S)-tylophorine (112 mg, 0.28 mmol) as a white solid:
D
dx.doi.org/10.1021/jo302725q | J. Org. Chem. XXXX, XXX, XXX−XXX